We evaluated secondary trapeziectomy for revision of trapeziometacarpal implants and compared this to primary trapeziectomy with a matched retrospective single centre study performed between October 2003 and February 2015. Thirty-one patients with trapeziometacarpal prosthesis failure who had a secondary trapeziectomy were matched with a primary trapeziectomy regarding sex, date of the operation and age. We evaluated function, mobility, autonomy, pain, strength, complications and shortening of the thumb on radiographs. The median time until removal of the implant was 37 months. The median age in both groups was similar. Median follow-up was more than 7 years in both groups. There was no statistically significant difference in terms of function, mobility, autonomy, pain, strength, complications and shortening of the thumb. Secondary trapeziectomy after revision of trapeziometacarpal implants provides results comparable with primary trapeziectomy. III.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/17531934211039184 | DOI Listing |
Rev Bras Ortop (Sao Paulo)
August 2024
Departamento de Cirurgia da Mão, Hospital Alvorada, São Paulo, SP, Brasil.
This study aimed to evaluate and compare the clinical and functional outcomes of two surgical procedures performed in patients with severe grade III and IV rhizarthrosis. We evaluated 39 patients who underwent two surgical techniques for rhizarthrosis treatment: trapeziectomy using the Kuhns technique or tendon interposition, with a minimum follow-up period of 6 months. The primary outcome assessment used the specific Trapeziometacarpal Arthrosis Symptoms and Disability (TASD) questionnaire, and the secondary outcome evaluation employed the shortened version of the Disabilities of the Arm, Shoulder, and Hand (QuickDASH) questionnaire and the visual analog scale (VAS).
View Article and Find Full Text PDFIr J Med Sci
December 2024
Department of Trauma and Orthopaedics, Connolly Hospital Blanchardstown, Dublin, Ireland.
Aims: The primary aim of this study was to assess functional and patient reported outcomes among those with first carpometacarpal joint osteoarthritis treated with the Pyrocardan implant (Stryker-Wright Medical) in Ireland. The secondary aim of this study was to assess implant survival and revision rates.
Methods: We conducted a single surgeon retrospective study assessing 40 Pyrocardan arthroplasties among 37 patients, with a minimum of 6 months follow-up.
BMJ Case Rep
July 2024
Department of Trauma and Orthopaedic Surgery, Raigmore Hospital, Inverness, UK
Cureus
May 2024
Orthopedic Surgery, Bahri Orthopedics and Sports Medicine Clinic, Jacksonville, USA.
Arthritis of the first carpometacarpal (CMC) joint is a common pathology hand surgeons encounter. Treatment begins with conservative measures, but when they fail, surgery is a viable option for providing relief to patients. The most widely used surgical technique is CMC arthroplasty with ligament reconstruction and tendon interposition (LRTI).
View Article and Find Full Text PDFJ Hand Surg Asian Pac Vol
June 2024
Section of Plastic Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!